Bank of Israel voted 5-0 to keep key rate at 4.5% in Feb, minutes show
JERUSALEM, March 10 (Reuters) - All five members of the Bank of Israel's monetary policy committee voted on Feb. 24 to leave the benchmark interest rate ILINR=ECI at 4.50%, minutes of the discussion showed on Monday.
With the impact of Israel's war with Hamas in Gaza, the committee's policy was focused on stabilising markets and reducing uncertainty in addition to price stability and support for economic activity, the central bank said in a statement accompanying the minutes.
"The interest rate path will be determined in
accordance with the convergence of inflation to its target, continued stability in the financial markets, economic activity, and fiscal policy," it said.
Policymakers remained concerned at the high level of inflation, which was at a 3.8% rate in January - above its 1-3% target.
The next rates decision is slated for April 7.
Related Articles
Micron Technology Q4 FY2025 Earnings Preview: Leveraging DRAM Strength and Accelerating HBM Growth
TradingKey - Micron Technology, Inc. (NASDAQ: MU) will report Q4 FY2025 results after the market close on Tuesday, September 23, 2025, with the webcasted conference call scheduled for 4:30 PM EDT. As a leading global supplier of memory chips, including DRAM, NAND flash, and advanced memory like...
Fed Rate Cuts: Will the Russell 2000 Outperform the S&P 500?
TradingKey - On 17 September, the Federal Reserve cut interest rates by 25 basis points, marking the official restart of the rate-cutting cycle. In theory, small-cap stocks, compared to large-cap stocks, benefit more from Fed rate cuts. This is because they are more reliant on external financing...
What Is Worldcoin? Why Did WLD Surge Suddenly, and What’s Next?
Worldcoin is evolving from a “hype token” into a foundational layer for global identity. Its fusion of biometrics, blockchain, and financial inclusion has earned growing recognition from users and institutions. If it can overcome technical hurdles, launch real-world payment use cases, and stabilize
From Ozempic to Wegovy: Growth and Risks Behind Novo Nordisk’s Q2 Performance
TradingKey - Novo Nordisk achieved revenue of $11.67 billion in Q2 of the 2025 fiscal year, a 19% increase year-over-year, but it fell short of market expectations. Growth was primarily driven by strong performance in obesity care and rare diseases.
ASML Q2 FY2025 Earnings Review: Strong Growth and High-NA EUV Breakthrough Shadowed by 2026 Uncertainty
ASML Holding N.V. (NASDAQ: ASML) released its Q2 FY2025 earnings on July 16, 2025, exceeding market expectations with robust net sales and net bookings, though the stock fell around 10% due to cautious guidance for 2026 amid geopolitical uncertainties.
